132
Participants
Start Date
February 28, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
February 28, 2015
Balanced anesthesia
Et-Sevo maIntained 1,8-2%, remifentanyl according target-controlled infusion maintained 1-3 ng/ml
Total intravenous anesthesia
Propofol 3-4 µg/ml and remifentanyl 1-3 ng/ml according target-controlled infusion
Regina Elena CI, Rome
Regina Elena Cancer Institute
OTHER